Phytopharm sees some hope in fight against Lou Gherig's disease

FTSE fledgling Phytopharm yesterday announced that a drug which originates from a traditional Chinese herbal remedy may provide hope for those suffering from motor neuron disease.

FTSE fledgling Phytopharm yesterday announced that a drug which originates from a traditional Chinese herbal remedy may provide hope for those suffering from motor neuron disease.

The drug development company said that early-stage tests in laboratory animals showed that the molecule under study, Cogane, had an impact in treating amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease, also widely known as Lou Gehrig's disease.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
MoneyWeek

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.